Sign in

CIK 0001566044

  • Non-accelerated filer
  • Smaller reporting company

Yarrow Bioscience, Inc.

Sign in to watch
Ticker
YARW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
453757789
Phone
+1 203-433-7577
Business address
470 JAMES STREET, SUITE 007, NEW HAVEN, CT, 06513
Former names
VYNE Therapeutics Inc., Menlo Therapeutics Inc., Menlo Therapeutics, Inc., Tigercat Pharma, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-05-28 Saik Andrew Chief Financial Officer Grant or award +3,017 $3.36 $10K 116,468
2021-03-31 Saik Andrew Chief Financial Officer Shares withheld for taxes −762 $6.84 $5K 113,451
2021-02-22 Saik Andrew Chief Financial Officer Grant or award +29,213 114,213
2021-02-22 Saik Andrew Chief Financial Officer Grant or award · Stock Options +68,162 68,162
2020-09-08 Saik Andrew Chief Financial Officer Purchase +40,000 $1.46 $58K 340,000
2020-05-06 Saik Andrew Chief Financial Officer Grant or award +250,000 300,000
2020-05-06 Saik Andrew Chief Financial Officer Grant or award · Stock Options +250,000 250,000
2020-03-23 Saik Andrew Chief Financial Officer Grant or award +50,000 50,000
2020-03-23 Saik Andrew Chief Financial Officer Grant or award · Stock Options +100,000 100,000

Page 1 of 1 · 9 trades